KYMERA THERAPEUTICS INC's ticker is KYMR and the CUSIP is 501575104. A total of 121 filers reported holding KYMERA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $81,429,842 | -39.5% | 5,858,262 | 0.0% | 12.61% | -24.8% |
Q2 2023 | $134,681,443 | -22.4% | 5,858,262 | 0.0% | 16.76% | -28.7% |
Q1 2023 | $173,580,303 | +16.2% | 5,858,262 | -2.1% | 23.50% | +30.6% |
Q4 2022 | $149,379,011 | -0.2% | 5,984,736 | -13.0% | 17.99% | +8.9% |
Q3 2022 | $149,684,000 | +10.6% | 6,875,698 | 0.0% | 16.52% | -27.0% |
Q2 2022 | $135,382,000 | -53.5% | 6,875,698 | 0.0% | 22.63% | -38.5% |
Q1 2022 | $290,980,000 | -33.3% | 6,875,698 | 0.0% | 36.79% | -8.3% |
Q4 2021 | $436,538,000 | – | 6,875,698 | – | 40.10% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Deer IX & Co. Ltd. | 1,755,356 | $97,949,000 | 48.97% |
Trustees of Columbia University in the City of New York | 463,298 | $28,724,000 | 38.38% |
AJU IB Investment Co., Ltd. | 704,059 | $43,652,000 | 16.52% |
BVF INC/IL | 2,630,658 | $163,101,000 | 6.42% |
Redmile Group, LLC | 2,720,489 | $168,670,000 | 2.04% |
Bain Capital Life Sciences Investors, LLC | 479,605 | $29,735,000 | 1.87% |
Rock Springs Capital Management LP | 713,865 | $44,260,000 | 0.94% |
SPHERA FUNDS MANAGEMENT LTD. | 147,700 | $9,157,000 | 0.81% |
HighVista Strategies LLC | 17,117 | $1,061,000 | 0.68% |
Logos Global Management LP | 110,920 | $6,877,000 | 0.59% |